US, Europe, and Brazil Alopecia Market

US, Europe, and Brazil Alopecia Market Size, Share, Growth Analysis, By Treatment(Surgical [Hair Transplant {Follicular Unit Transplantation (FUT), and Follicular Unit Extraction (FUE)}, Alopecia Scalp Reduction, Scalp Expansion), By Region - Industry Forecast 2024-2031


Report ID: SQMIU35I2334 | Region: US, Europe, and Brazil | Published Date: July, 2024
Pages: 165 | Tables: 50 | Figures: 74

US, Europe, and Brazil Alopecia Market Insights

US, Europe, and Brazil Alopecia Market size was valued at USD 27.81 Billion in 2022 and is poised to grow from USD 29.96 Billion in 2023 to USD 54.23 Billion by 2031, growing at a CAGR of 7.7% in the forecast period (2024-2031).

The market for alopecia in US, Europe and Brazil has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.

The market for treating alopecia has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.

Over the course of the forecast period, the hair loss industry's market landscape is expected to be characterised by an increased focus on the provision of hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as by an increase in the penetration of cutting-edge hair loss treatment therapies like stem cell therapy. The number of people treated for hair loss is anticipated to increase with the advent of low-level laser therapy, which helps encourage hair growth. Additionally, the advent of laser hats, helmets, combs, and bands is anticipated to spur market expansion. The Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are a few of the cutting-edge goods available today.

$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US, Europe, and Brazil Alopecia Market size was valued at USD 27.81 Billion in 2022 and is poised to grow from USD 29.96 Billion in 2023 to USD 54.23 Billion by 2031, growing at a CAGR of 7.7% in the forecast period (2024-2031).

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion. 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Mylan N.V. (US)', 'Teva Pharmaceutical Industries Ltd. (Ireland)', 'Sanofi (France)', 'Pfizer Inc. (US)', 'GlaxoSmithKline plc (UK)', 'Novartis AG (Switzerland)', 'Bayer AG (Germany)', 'Eli Lilly and Company (US)', 'Merck & Co., Inc. (US)', 'Allergan (Ireland)', 'AstraZeneca (UK)', 'AbbVie Inc. (US)', 'Johnson & Johnson Private Limited (US)', 'Cipla Inc. (US)   ', 'Abbott Pharmacy (US)', 'BioNike (Italy)', 'Daichii Sanko (Japan)', 'Theradome (US)', 'Lutronic Corporation (US)'

According to SkyQuest’s analysis, the rising incidence of alopecia areata drives the alopecia market in the North America region. This disease affects 6.7 million in the U.S. and 160 million in the world, making the market large in opportunity. Alopecia does not favours anybody; it affects both men and women; patient constitutions span all age groups. Up to 9 percent of relatives are affected, hinting at a potential hereditary link. It complicates the treatment of alopecia areata through possible comorbidity with other autoimmune diseases, and hence complex and innovative treatments are needed. The high demand for remedial solutions results from the collective operation of all these factors, which helps the alopecia market grow substantially.

Integration of Telemedicine & Remote Patient Consultations: Telemedicine is revolutionizing health care. It is facilitating access for alopecia patients through companies like TelMDcare. Virtual consultations to dermatologists allow home diagnosis and treatment, thus increasing access and convenience. This will facilitate timely interventions to be effected since symptoms can track the development of hair loss. It expands a healthcare provider's patient base to the remote and underserved populations, covering gaps in access to specialized care. Moreover, the application of telemedicine will help health providers bring alopecia patients closer to management, thus improving patients' outcomes and overall satisfaction considerably.

In 2023, US dominated the market and had the highest revenue share (60.01%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

US, Europe, and Brazil Alopecia Market

Report ID: SQMIU35I2334

$3,500
BUY NOW GET FREE SAMPLE